← Leaderboards
Geraldine Waloga
Adipogenix, Inc.
$1,477,732
Attributed
$1,477,732
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,477,732 · 2
By mechanism
R44$1,477,732 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug Design /Synthesis /Production”
- Dennis L. Kasper · Harvard Medical School$26,605,444
- Myron Max Levine · University Of Maryland Baltimore$22,074,862
- George R Painter · Chimerix, Inc.$19,230,662
- Donald L Fine · Dynport Vaccine Company, Llc$9,996,228
- Dennis E. Hruby · Oregon State University$9,654,233
- William C Olson · Progenics Pharmaceuticals, Inc.$8,361,679
Research focus
Drug Design /Synthesis /ProductionTissue /Cell CultureObesityAdipocytesHyperplasiaCell DifferentiationCell Population StudyDrug Screening /EvaluationFluorescent Dye /ProbeHuman TissueHypertrophyInhibitor /AntagonistPeroxisome Proliferator Activated ReceptorStem CellsTechnology /Technique DevelopmentChemical SynthesisToxicologyWestern BlottingsChemical Structure FunctionPatient Oriented ResearchBiotherapeutic AgentPharmacokineticsClinical ResearchCombinatorial Chemistry
Grant awards (4)
New Agents That Inhibit Fatty Acid Accumulation$276,424
R44 · FY2005 · DK
New Agents That Inhibit Fatty Acid Accumulation$446,920
R44 · FY2004 · DK
Anti-obesity drug development using human preadipocytes$151,917
R44 · FY2002 · DK
Anti-obesity drug development using human preadipocytes$602,471
R44 · FY2001 · DK